Hemotune
Founded 2017 · 32 employees on LinkedIn · 6 known investors
Find your way into Hemotune
Sign up to see every warm intro you have to Hemotune
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Hemotune team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
hemotune develops a magnetic nanoparticle platform for targeted magnetic separation in medical and biomanufacturing applications. The platform removes disease triggers and harmful agents from the bloodstream or processes biological materials with high selectivity and scalability.
Investors · 6
How we know: funding news · hemotune.com · Not right? Tell us
Also in the syndicate · 5
Funding
SEC filings, press & company announcements- Undisclosed amountSeries B2Mar 2024 · 2 sources
Belmondo (lead), EFI, HEMEX, OCCIDENT, VP Venture Partners, ZKB
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through Hemotune went on to found or lead other companies.
Frequently asked questions
- What does Hemotune do?
- hemotune develops a magnetic nanoparticle platform for targeted magnetic separation in medical and biomanufacturing applications. The platform removes disease triggers and harmful agents from the bloodstream or processes biological materials with high selectivity and scalability.
- Who are Hemotune's investors?
- Hemotune's investors include OCCIDENT.



